Keynote Financial Services’s Gilead Sciences GILD Stock Holding History

Keynote Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54M	Buy	12,178 +276	+2%	+$36.4K	0.72%	40
2026 Q1	$1.66M	Sell	11,902 -41	-0.3%	-$5.74K	0.88%	34
2025 Q4	$1.47M	Sell	11,943 -64	-0.5%	-$7.78K	0.82%	34
2025 Q3	$1.33M	Sell	12,007 -385	-3%	-$43.8K	0.8%	34
2025 Q2	$1.37M	Hold	12,392	–	–	0.92%	30
2025 Q1	$1.39M	Sell	12,392 -130	-1%	-$13.4K	0.99%	29
2024 Q4	$1.16M	Sell	12,522 -55	-0.4%	-$4.95K	0.89%	33
2024 Q3	$1.05M	Buy	12,577 +141	+1%	+$10.8K	0.81%	39
2024 Q2	$853K	Buy	12,436 +895	+8%	+$59.7K	0.71%	44
2024 Q1	$845K	Buy	+11,541	New	+$887K	0.71%	43

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keynote Financial Services's GILD Position: Q2 2026 in Review

Keynote Financial Services increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $36.4K and bringing the position to 12,178 shares worth $1.54M. The position accounts for 0.72% of the portfolio, ranked #40.

Keynote Financial Services first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.66M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Keynote Financial Services held 12,178 shares of Gilead Sciences worth $1.54M as of Q2 2026.
Keynote Financial Services bought 276 Gilead Sciences shares in Q2 2026, an estimated $36.4K.
Gilead Sciences made up 0.72% of Keynote Financial Services's portfolio in Q2 2026, its #40 holding.
Keynote Financial Services first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
Keynote Financial Services's Gilead Sciences position peaked at $1.66M in Q1 2026.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.